Drug · DIN 02456478
RUPALL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 2, 2023; first marketed January 20, 2017.
- Drug Identification Number (DIN)
- 02456478
- Company (DIN owner)
- Medexus Pharmaceuticals Inc.Bolton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Oral
- Therapeutic class (ATC)
- Rupatadine R06AX28
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RUPATADINE (RUPATADINE FUMARATE) | 1 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 2, 2023: NOC 30035New Drug Submission (NDS) · Administrative: Change in Product Ownership
- June 4, 2020: NOC 23717New Drug Submission (NDS) · Administrative: Merger/Buy-out
- July 20, 2016: NOC 18290New Drug Submission (NDS)
Other DINs named RUPALL
- DIN 02456451 · Marketed